medicare

The 340B Drug Pricing Program has operated since 1992 on a straightforward premise: pharmaceutical manufacturers must sell drugs at steep discounts to hospitals and clinics that serve disproportionate shares of low-income and uninsured patients, and those savings are meant to help those facilities extend their financial capacity to serve people who would otherwise go without…